Drawing for Serial No. 90071614

USPTO serial 90071614

Serial No. 90071614

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WITKOWSKI, RYAN MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 90071614?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura Ganoza

Laura Ganoza FOLEY & LARDNER LLP2 SOUTH BISCAYNE BOULEVARDONE BISCAYNE TOWER, SUITE 1900MIAMI, FL 33131

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software using artificial intelligence in healthcare and medical field to assess medical conditions; computer hardware and recorded software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software for providing an on-line database in the field of transaction processing to upload transactional data, provide statistical analysis, produce notifications and reports and integrate data from other software and medical devices; headsets for use with computers; downloadable mobile application for generation of reports, digital images and video clips in the medical and health care fields; downloadable mobile application for viewing medical and healthcare data files; downloadable application programming interface (API) software used to assess brain diseases, investigate efficacy of various drugs, and enable treatment of medical conditionsACTIVE—
010Medical devices, namely, devices for measuring cerebral blood flow; medical apparatus and instruments for measuring cerebral blood flow and assessment of neurological conditions and other medical conditions; medical devices for assessment of neurological conditions; medical devices for enabling treatment of neurological conditions; medical devices for ultrasonography; medical devices, namely, transcranial doppler ultrasound devices; medical imaging devices for the brain; medical devices for automated assessment of medical conditions; medical ultrasound apparatus; diagnostic headsets for medical use for assessing medical conditions, for assessing neurological conditions, and for measuring cerebral blood flow; medical devices, namely, diagnostic headsets for assessing medical conditions, for assessing neurological conditions, and for measuring cerebral blood flow; kits for a transcranial doppler ultrasound scan comprised of medical ultrasound apparatus; medical robots with ultrasound apparatus for assessing neurological conditions, and for measuring cerebral blood flowACTIVE—
035Data analytics subscription management services delivered through digital platforms for physician and healthcare systems; compilation of statistics; compilation and systemization of information into computer databases; computerized file management; compilation of business data into computer databasesACTIVE—
036Extended warranty services, namely, service contracts; providing extended warranties on medical devicesACTIVE—
041Educational services, namely, providing online and in-person instruction in the medical field for doctors, sonographers, and nurses; continuing education services, namely, providing in-person training and on-line and in-person continuing professional education lectures, seminars and classes in the medical fieldACTIVE—
042Development of computer software application solutions using artificial intelligence and machine learning; scientific computer programming services; development of systems for the processing of data; cloud computing and computer integration services featuring software for the assessing and enabling treatment of medical conditions; software as a service (SAAS) featuring software for the assessing and enabling treatment of medical conditions; cloud services in the nature of software as a service (SAAS) for the assessing and enabling treatment of medical conditions; application service provider featuring application programming interface (API) software for use by doctors and pharmacists on a database to assess brain diseases, investigate efficacy of various drugs, and enable treatment of medical conditions; scientific research, medical research; Compiling data for research purposes in the field of medical science and medical consultancy; analysis of medical data for medical research purposesACTIVE—
044Medical services; medical ultrasound imaging services; medical services, namely, monitoring of patients; human healthcare services, namely, medical analysis of neurological conditions and other medical conditions for diagnostic and treatment purposes; telemedicine services; Analysis of medical data for diagnostic and treatment purposes; consulting services in the field of medical care and assessment of neurological conditions; maintaining patient medical records and filesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 25, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 25, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 26, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 19, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 23, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2023EX4GSOU EXTENSION 4 GRANTED—
Feb 21, 2023EXT4SOU EXTENSION 4 FILED—
Feb 21, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 20, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 18, 2022EX3GSOU EXTENSION 3 GRANTED—
Aug 18, 2022EXT3SOU EXTENSION 3 FILED—
Aug 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 22, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 18, 2022EX2GSOU EXTENSION 2 GRANTED—
Feb 18, 2022EXT2SOU EXTENSION 2 FILED—
Feb 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 25, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 23, 2021EX1GSOU EXTENSION 1 GRANTED—
Aug 23, 2021EXT1SOU EXTENSION 1 FILED—
Aug 23, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 23, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 29, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 29, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 9, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 22, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Nov 17, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 17, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 17, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 10, 2020DOCKASSIGNED TO EXAMINER—
Aug 22, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance